These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 18188086)

  • 1. The effects of rheumatoid arthritis on labor force participation, work performance, and healthcare costs in two workplace samples.
    Kessler RC; Maclean JR; Petukhova M; Sarawate CA; Short L; Li TT; Stang PE
    J Occup Environ Med; 2008 Jan; 50(1):88-98. PubMed ID: 18188086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Employer model of workplace impacts of anti-TNF therapy for rheumatoid arthritis.
    Birnbaum H; Pike C; Kaufman R; Cifaldi M
    J Occup Environ Med; 2009 Oct; 51(10):1167-76. PubMed ID: 19786900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The indirect costs of arthritis resulting from unemployment, reduced performance, and occupational changes while at work.
    Li X; Gignac MA; Anis AH
    Med Care; 2006 Apr; 44(4):304-10. PubMed ID: 16565630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Work limitations among working persons with rheumatoid arthritis: results, reliability, and validity of the work limitations questionnaire in 836 patients.
    Walker N; Michaud K; Wolfe F
    J Rheumatol; 2005 Jun; 32(6):1006-12. PubMed ID: 15940759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Employee Absenteeism Costs of Rheumatoid Arthritis: Evidence From US National Survey Data.
    Gunnarsson C; Chen J; Rizzo JA; Ladapo JA; Naim A; Lofland JH
    J Occup Environ Med; 2015 Jun; 57(6):635-42. PubMed ID: 26053366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absenteeism and Employer Costs Associated With Chronic Diseases and Health Risk Factors in the US Workforce.
    Asay GR; Roy K; Lang JE; Payne RL; Howard DH
    Prev Chronic Dis; 2016 Oct; 13():E141. PubMed ID: 27710764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of rheumatoid arthritis on the burden of disease in urban China.
    Langley PC; Mu R; Wu M; Dong P; Tang B
    J Med Econ; 2011; 14(6):709-19. PubMed ID: 21899486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The economic burden of disease: comparison between rheumatoid arthritis and ankylosing spondylitis.
    Boonen A; Mau W
    Clin Exp Rheumatol; 2009; 27(4 Suppl 55):S112-7. PubMed ID: 19822056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The economic consequences of rheumatoid arthritis: analysis of Medical Expenditure Panel Survey 2004, 2005, and 2006 data.
    Simons WR; Rosenblatt LC; Trivedi DN
    J Occup Environ Med; 2012 Jan; 54(1):48-55. PubMed ID: 22227873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of etanercept on work and activity impairment in employed moderate to severe rheumatoid arthritis patients in the United States.
    Hone D; Cheng A; Watson C; Huang B; Bitman B; Huang XY; Gandra SR
    Arthritis Care Res (Hoboken); 2013 Oct; 65(10):1564-72. PubMed ID: 23554320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling the impact of enhanced depression treatment on workplace functioning and costs: a cost-benefit approach.
    Lo Sasso AT; Rost K; Beck A
    Med Care; 2006 Apr; 44(4):352-8. PubMed ID: 16565636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rheumatoid arthritis is already expensive during the first year of the disease (the Swedish TIRA project).
    Hallert E; Husberg M; Jonsson D; Skogh T
    Rheumatology (Oxford); 2004 Nov; 43(11):1374-82. PubMed ID: 15280570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with absenteeism, presenteeism and activity impairment in patients in the first years of RA.
    Bansback N; Zhang W; Walsh D; Kiely P; Williams R; Guh D; Anis A; Young A
    Rheumatology (Oxford); 2012 Feb; 51(2):375-84. PubMed ID: 22179728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A multicenter cross-sectional study on the health related quality of life of patients with rheumatoid arthritis using a revised Japanese version of the arthritis impact measurement scales version 2 (AIMS 2), focusing on the medical care costs and their associative factors].
    Hashimoto A; Sato H; Nishibayahi Y; Shiino Y; Kutsuna T; Ishihara Y; Hoshi K; Fujimori J; Tsuboi S; Kondo H; Akizuki M; Moroi Y; Yoshida S
    Ryumachi; 2002 Feb; 42(1):23-39. PubMed ID: 11925904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indirect cost assessment in patients with rheumatoid arthritis (RA): comparison of data from the health economic patient questionnaire HEQ-RA and insurance claims data.
    Merkesdal S; Ruof J; Huelsemann JL; Mittendorf T; Handelmann S; Mau W; Zeidler H
    Arthritis Rheum; 2005 Apr; 53(2):234-40. PubMed ID: 15818718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rheumatoid arthritis and work: The impact of rheumatoid arthritis on absenteeism and presenteeism.
    Verstappen SM
    Best Pract Res Clin Rheumatol; 2015 Jun; 29(3):495-511. PubMed ID: 26612244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Societal costs of rheumatoid arthritis in Hong Kong: a prevalence-based cost-of-illness study.
    Zhu TY; Tam LS; Li EK
    Rheumatology (Oxford); 2011 Jul; 50(7):1293-301. PubMed ID: 21330341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of the Stanford Health Assessment Questionnaire in estimation of long-term productivity costs in patients with recent-onset rheumatoid arthritis.
    Puolakka K; Kautiainen H; Mottonen T; Hannonen P; Korpela M; Hakala M; Luukkainen R; Vuori K; Blåfield H; Leirisalo-Repo M
    Scand J Rheumatol; 2009; 38(2):96-103. PubMed ID: 19274516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of rheumatoid arthritis on medical expenditures, absenteeism, and short-term disability benefits.
    Ozminkowski RJ; Burton WN; Goetzel RZ; Maclean R; Wang S
    J Occup Environ Med; 2006 Feb; 48(2):135-48. PubMed ID: 16474262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-of-illness of rheumatoid arthritis and ankylosing spondylitis.
    Franke LC; Ament AJ; van de Laar MA; Boonen A; Severens JL
    Clin Exp Rheumatol; 2009; 27(4 Suppl 55):S118-23. PubMed ID: 19822057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.